Furthermore, a direct comparison of [111In]In-DTPA-hEGF with the anti-HER1 monoclonal antibody MAb 528 demonstrated much lower tumor uptake, surprisingly higher liver uptake, and notably lower tumor-to-tissue ratios for [111In]In-DTPA-hEGF [110]. This evidence concerns the gene EGFR and neoplasm.